BioSpace News Archive

Toshiba Corporation and Toshiba Digital Solutions Corporation, industry leaders in solutions for large-scale optimization problems, announced the Ballistic Simulated Bifurcation Algorithm and the Discrete Simulated Bifurcation Algorithm, new algorithms that far surpass the performance of Toshiba’s previous Simulated Bifurcation Algorithm.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the publication of a US multicenter study showing that the iTind provides rapid and effective relief of symptoms through a catheter-free procedure that preserves sexual function for men with an enlarged prostate.

Baxter Reports Fourth-quarter sales of $3.2 billion increased 5% on a reported basis, 3% on a constant currency basis and 2% on an operational basis 1 Fourth-quarter U.S. GAAP earnings per share (EPS) were $0.33 and adjusted EPS were $0.80 Full-year revenue of $11.7 billion increased 3% on both a reported and constant currency basis and 2% on an operational basis

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that the United States Food and Drug Administration (FDA) has granted fast track designation to TH1902 as a single agent for the treatment of patients with sortilin positive recurrent advanced solid tumors that are refractory to standard therapy.

Novel immunotherapy approach designed to stimulate immune response by activating B cells to enhance polyclonal antibody production and potentially reduce hospitalization and progression to respiratory failure Randomized, double-blind, placebo-controlled study expected to enroll ~1,000 patients across global sites with results expected in Q4 2021 Company to host conference call and webcast today at 8:30 a.m. ET / 5:30 a.m. PT

A study published in the journal Pediatrics expands validation evidence for a new screening tool that directly engages preschool-age children during clinic visits to assess their early literacy skills.

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2020 earnings release and conference call.

Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, announced that management will present at two upcoming virtual investor conferences:

Dalrada Financial Corp. (OTCQB: DFCO, “Dalrada”) is pleased to announce that Dalrada Heath has finalized the Company’s acquisition of U.S.-based Pacific Stem Cells, LLC.

Avitide, Inc. the industry leader in the discovery and development of affinity purification chromatography resins, announced that it has finalized the development of an affinity bioprocess resin for the purification of recombinant COVID-19 vaccines